Chemical synthesis of glycosaminoglycans : new approaches to antithrombotic drugs
Sanofi, Elf Aquitaine's pharmaceutical subsidiary, is a world leader in the manufacturing of antithrombotic drugs. The development of Heparin-based antithrombotic drugs is traced and the company's progress in producing synthetic substitutes is discussed.
Gespeichert in:
| Veröffentlicht in: | Nature (London) 1991-04, Vol.350 (6319), p.30-33 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 33 |
|---|---|
| container_issue | 6319 |
| container_start_page | 30 |
| container_title | Nature (London) |
| container_volume | 350 |
| creator | PETITOU, M LORMEAU, J.-C CHOAY, J |
| description | Sanofi, Elf Aquitaine's pharmaceutical subsidiary, is a world leader in the manufacturing of antithrombotic drugs. The development of Heparin-based antithrombotic drugs is traced and the company's progress in producing synthetic substitutes is discussed. |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_80516988</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80516988</sourcerecordid><originalsourceid>FETCH-LOGICAL-p295t-3701eab104e1916b4c707cd4dcc5a4b5f4060309fb7d12613fce08f638cf1bdd3</originalsourceid><addsrcrecordid>eNp90M1LwzAUAPAgypzTP0EIgnoqvKRpknqT4RcMRNBzSdNky2iT2bTI_nszLB48eHoP3o_3dYTmhAmeMS7FMZoDUJmBzPkpOotxCwAFEWyGZhSIoJzO0dtyYzqnVYvj3g8bE13EweJ1u9chqs75cEiVj_gOe_OF1W7XB6UTxEPAyg9u2PShq8PgNG76cR3P0YlVbTQXU1ygj8eH9-Vztnp9elner7IdLYshywUQo2oCzJCS8JppAUI3rNG6UKwuLAMOOZS2Fg2hnORWG5CW51JbUjdNvkA3P33TQp-jiUPVuahN2ypvwhgrmW7lpZQJ3v4LBcsJ4VzyJK_-yG0Ye5-uqCgwxoqiPKDLCY11Z5pq17tO9ftqemmqX091FdNfba-8dvGXkVKCpGnmN5_GgCc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>204445596</pqid></control><display><type>article</type><title>Chemical synthesis of glycosaminoglycans : new approaches to antithrombotic drugs</title><source>MEDLINE</source><source>Nature</source><source>Alma/SFX Local Collection</source><creator>PETITOU, M ; LORMEAU, J.-C ; CHOAY, J</creator><creatorcontrib>PETITOU, M ; LORMEAU, J.-C ; CHOAY, J</creatorcontrib><description>Sanofi, Elf Aquitaine's pharmaceutical subsidiary, is a world leader in the manufacturing of antithrombotic drugs. The development of Heparin-based antithrombotic drugs is traced and the company's progress in producing synthetic substitutes is discussed.</description><identifier>ISSN: 0028-0836</identifier><identifier>EISSN: 1476-4687</identifier><identifier>PMID: 2017262</identifier><identifier>CODEN: NATUAS</identifier><language>eng</language><publisher>London: Nature Publishing</publisher><subject>Biological and medical sciences ; Blood. Blood coagulation. Reticuloendothelial system ; Carbohydrate Conformation ; Carbohydrate Sequence ; Cardiovascular disease ; Computer Graphics ; Corporate profiles ; Drugs ; Factor Xa Inhibitors ; Fibrinolytic Agents - chemical synthesis ; Glycosaminoglycans - chemical synthesis ; Heparin - chemistry ; Humans ; Medical sciences ; Models, Molecular ; Molecular Sequence Data ; Oligosaccharides - chemical synthesis ; Oligosaccharides - pharmacology ; Pharmaceutical industry ; Pharmacology. Drug treatments ; Product development ; Synthetic products</subject><ispartof>Nature (London), 1991-04, Vol.350 (6319), p.30-33</ispartof><rights>1991 INIST-CNRS</rights><rights>Copyright Macmillan Journals Ltd. Apr 18, 1991</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19808274$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2017262$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>PETITOU, M</creatorcontrib><creatorcontrib>LORMEAU, J.-C</creatorcontrib><creatorcontrib>CHOAY, J</creatorcontrib><title>Chemical synthesis of glycosaminoglycans : new approaches to antithrombotic drugs</title><title>Nature (London)</title><addtitle>Nature</addtitle><description>Sanofi, Elf Aquitaine's pharmaceutical subsidiary, is a world leader in the manufacturing of antithrombotic drugs. The development of Heparin-based antithrombotic drugs is traced and the company's progress in producing synthetic substitutes is discussed.</description><subject>Biological and medical sciences</subject><subject>Blood. Blood coagulation. Reticuloendothelial system</subject><subject>Carbohydrate Conformation</subject><subject>Carbohydrate Sequence</subject><subject>Cardiovascular disease</subject><subject>Computer Graphics</subject><subject>Corporate profiles</subject><subject>Drugs</subject><subject>Factor Xa Inhibitors</subject><subject>Fibrinolytic Agents - chemical synthesis</subject><subject>Glycosaminoglycans - chemical synthesis</subject><subject>Heparin - chemistry</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Models, Molecular</subject><subject>Molecular Sequence Data</subject><subject>Oligosaccharides - chemical synthesis</subject><subject>Oligosaccharides - pharmacology</subject><subject>Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Product development</subject><subject>Synthetic products</subject><issn>0028-0836</issn><issn>1476-4687</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90M1LwzAUAPAgypzTP0EIgnoqvKRpknqT4RcMRNBzSdNky2iT2bTI_nszLB48eHoP3o_3dYTmhAmeMS7FMZoDUJmBzPkpOotxCwAFEWyGZhSIoJzO0dtyYzqnVYvj3g8bE13EweJ1u9chqs75cEiVj_gOe_OF1W7XB6UTxEPAyg9u2PShq8PgNG76cR3P0YlVbTQXU1ygj8eH9-Vztnp9elner7IdLYshywUQo2oCzJCS8JppAUI3rNG6UKwuLAMOOZS2Fg2hnORWG5CW51JbUjdNvkA3P33TQp-jiUPVuahN2ypvwhgrmW7lpZQJ3v4LBcsJ4VzyJK_-yG0Ye5-uqCgwxoqiPKDLCY11Z5pq17tO9ftqemmqX091FdNfba-8dvGXkVKCpGnmN5_GgCc</recordid><startdate>19910418</startdate><enddate>19910418</enddate><creator>PETITOU, M</creator><creator>LORMEAU, J.-C</creator><creator>CHOAY, J</creator><general>Nature Publishing</general><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7SN</scope><scope>7SS</scope><scope>7ST</scope><scope>7T5</scope><scope>7TG</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>KL.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope><scope>SOI</scope><scope>7SC</scope><scope>7SP</scope><scope>7SR</scope><scope>7TB</scope><scope>7U5</scope><scope>8BQ</scope><scope>F28</scope><scope>JG9</scope><scope>JQ2</scope><scope>KR7</scope><scope>L7M</scope><scope>L~C</scope><scope>L~D</scope><scope>7X8</scope></search><sort><creationdate>19910418</creationdate><title>Chemical synthesis of glycosaminoglycans : new approaches to antithrombotic drugs</title><author>PETITOU, M ; LORMEAU, J.-C ; CHOAY, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p295t-3701eab104e1916b4c707cd4dcc5a4b5f4060309fb7d12613fce08f638cf1bdd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Biological and medical sciences</topic><topic>Blood. Blood coagulation. Reticuloendothelial system</topic><topic>Carbohydrate Conformation</topic><topic>Carbohydrate Sequence</topic><topic>Cardiovascular disease</topic><topic>Computer Graphics</topic><topic>Corporate profiles</topic><topic>Drugs</topic><topic>Factor Xa Inhibitors</topic><topic>Fibrinolytic Agents - chemical synthesis</topic><topic>Glycosaminoglycans - chemical synthesis</topic><topic>Heparin - chemistry</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Models, Molecular</topic><topic>Molecular Sequence Data</topic><topic>Oligosaccharides - chemical synthesis</topic><topic>Oligosaccharides - pharmacology</topic><topic>Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Product development</topic><topic>Synthetic products</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>PETITOU, M</creatorcontrib><creatorcontrib>LORMEAU, J.-C</creatorcontrib><creatorcontrib>CHOAY, J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Environment Abstracts</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>Environment Abstracts</collection><collection>Computer and Information Systems Abstracts</collection><collection>Electronics & Communications Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Mechanical & Transportation Engineering Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>ANTE: Abstracts in New Technology & Engineering</collection><collection>Materials Research Database</collection><collection>ProQuest Computer Science Collection</collection><collection>Civil Engineering Abstracts</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Computer and Information Systems Abstracts Academic</collection><collection>Computer and Information Systems Abstracts Professional</collection><collection>MEDLINE - Academic</collection><jtitle>Nature (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>PETITOU, M</au><au>LORMEAU, J.-C</au><au>CHOAY, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chemical synthesis of glycosaminoglycans : new approaches to antithrombotic drugs</atitle><jtitle>Nature (London)</jtitle><addtitle>Nature</addtitle><date>1991-04-18</date><risdate>1991</risdate><volume>350</volume><issue>6319</issue><spage>30</spage><epage>33</epage><pages>30-33</pages><issn>0028-0836</issn><eissn>1476-4687</eissn><coden>NATUAS</coden><abstract>Sanofi, Elf Aquitaine's pharmaceutical subsidiary, is a world leader in the manufacturing of antithrombotic drugs. The development of Heparin-based antithrombotic drugs is traced and the company's progress in producing synthetic substitutes is discussed.</abstract><cop>London</cop><pub>Nature Publishing</pub><pmid>2017262</pmid><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0028-0836 |
| ispartof | Nature (London), 1991-04, Vol.350 (6319), p.30-33 |
| issn | 0028-0836 1476-4687 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_80516988 |
| source | MEDLINE; Nature; Alma/SFX Local Collection |
| subjects | Biological and medical sciences Blood. Blood coagulation. Reticuloendothelial system Carbohydrate Conformation Carbohydrate Sequence Cardiovascular disease Computer Graphics Corporate profiles Drugs Factor Xa Inhibitors Fibrinolytic Agents - chemical synthesis Glycosaminoglycans - chemical synthesis Heparin - chemistry Humans Medical sciences Models, Molecular Molecular Sequence Data Oligosaccharides - chemical synthesis Oligosaccharides - pharmacology Pharmaceutical industry Pharmacology. Drug treatments Product development Synthetic products |
| title | Chemical synthesis of glycosaminoglycans : new approaches to antithrombotic drugs |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T00%3A12%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chemical%20synthesis%20of%20glycosaminoglycans%20:%20new%20approaches%20to%20antithrombotic%20drugs&rft.jtitle=Nature%20(London)&rft.au=PETITOU,%20M&rft.date=1991-04-18&rft.volume=350&rft.issue=6319&rft.spage=30&rft.epage=33&rft.pages=30-33&rft.issn=0028-0836&rft.eissn=1476-4687&rft.coden=NATUAS&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E80516988%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=204445596&rft_id=info:pmid/2017262&rfr_iscdi=true |